Drug addiction and the newborn.
D000661:Amphetamine / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001463:Barbiturates / Q000009:adverse effects; D002188:Cannabis / Q000009:adverse effects; D002669:Child Welfare; D002746:Chlorpromazine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D003932:Heroin / Q000009:adverse effects; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy
D014150:Antipsychotic Agents; D001463:Barbiturates; D003932:Heroin; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D003975:Diazepam; D002746:Chlorpromazine